Compass Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Compass Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Compass Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Compass Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $228k | 157k | 1.45 |
| 2024-09-30 | $427k | 232k | 1.84 |
| 2024-06-30 | $232k | 232k | 1.00 |
| 2024-03-31 | $477k | 241k | 1.98 |
| 2023-12-31 | $332k | 213k | 1.56 |
| 2023-09-30 | $262k | 133k | 1.97 |
| 2023-06-30 | $366k | 115k | 3.18 |
| 2023-03-31 | $74k | 23k | 3.27 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management